THE WIRE
What insiders and companies just did: insiders buying and selling with their own money, company news, new 5% stakes and new shares registered.
BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing
Key
BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing
Newest first. Insider rows are open-market purchases and sales; several by one company are one row, open it for each.
- SDEVStablecoin Development CorpShareholder vote.−40.6%8-K 5.07 ↗
- ICMBInvestcorp Credit Management BDC, IncMaterial agreement and Regulation FD disclosure.
Investcorp Credit Management BDC, Inc. to Merge into BCP Investment Corporation
+57.9%8-K 1.01 ↗ - MBRXMoleculin Biotech, IncRegulation FD disclosure.
Moleculin Secures Australian Patent for Annamycin Formulation Technology Patent strengthens intellectual property protection for preparation of preliposomal Annamycin lyophilizate
−4.4%8-K 7.01 ↗ - ONEWOneWater Marine IncMaterial agreement and Regulation FD disclosure.
OneWater Marine Inc. Extends Term Loan and Floor Plan Credit Facilities to 2029
−2.4%8-K 1.01 ↗ - BCICBCP Investment CorpMaterial agreement and Regulation FD disclosure.
Investcorp Credit Management BDC, Inc. to Merge into BCP Investment Corporation
−20.5%8-K 1.01 ↗ - CTVACorteva, IncResults of operations.−35.0%8-K 2.02 ↗
- EFCEllington Financial IncOther events.
Ellington Financial Announces Sale of MSR Assets *Completes Monetization of All Material Arlington Assets*
−1.4%8-K 8.01 ↗ - STIMNeuronetics, IncMaterial agreement and other events.
Neuronetics Announces Proposed Public Offering of Common Stock
−22.8%8-K 1.01 ↗ - AENTAlliance Entertainment Holding CorpResults of operations and Regulation FD disclosure.
Gross profit increased 13% to $42.1 million; gross margin expanded to 15.1% Physical movie revenue increased 20%; vinyl revenue rose 14% and CD revenue grew 22% Collectibles revenue increased 87%
+1.3%8-K 2.02 ↗ - DFDVDeFi Development CorpOfficer or director change and Regulation FD disclosure.
DeFi Development Corp. Promotes John Han to Chief Operating Officer While Continuing as CFO
−33.3%8-K 5.02 ↗ - TULPBloomia Holdings, IncResults of operations.−1.3%8-K 2.02 ↗
- VNRXVolitionrx LTDOfficer or director change.−19.0%8-K 5.02 ↗
- NSYSNortech Systems IncResults of operations.−1.4%8-K 2.02 ↗
- NTRPNextTrip, IncRegulation FD disclosure.
NextTrip Advances Cruise Strategy, Connecting JOURNY TV Programming and Digital Booking Tools with Personalized Travel Advisor Support Initiative builds on growth in Five Star Alliance’s cruise…
−32.3%8-K 7.01 ↗ - GTBPGT Biopharma, IncShareholder vote.−25.1%8-K 5.07 ↗
- HTCRHeartCore Enterprises, IncRegulation FD disclosure.
HeartCore Partners with ONE AI to Bring Physical AI to Existing Industrial Robots in Japan Axis.ONE is designed to add vision, decision-making and learning to existing factory equipment without…
−12.2%8-K 7.01 ↗ - VWAVVisionWave Holdings, IncOther events.−82.5%8-K 8.01 ↗
- TLNTalen Energy CorpOther events.−12.1%8-K 8.01 ↗
- VANIVivani Medical, IncResults of operations and Regulation FD disclosure.+0.9%8-K 2.02 ↗
- SGPSpyGlass Pharma, IncResults of operations and other events.−13.0%8-K 2.02 ↗
- CLVTClarivate PLCOther events.−13.4%8-K 8.01 ↗
- ONDSOndas IncResults of operations.−34.4%8-K 2.02 ↗
- MOVECorvex, IncResults of operations.
Corvex Reports Third Quarter 2026 Results
−42.6%8-K 2.02 ↗ - FLNAFilana Therapeutics, IncOfficer or director change and Regulation FD disclosure.
Filana Therapeutics Names Biopharma Executive Jill M. Quigley to Board –Appointment brings leadership experience building and financing biopharma companies
+33.0%8-K 5.02 ↗ - RUMRUM Group IncResults of operations and Regulation FD disclosure.−29.7%8-K 2.02 ↗
- TRMKTrustmark CorpRegulation FD disclosure.
Hancock Whitney Corporation to acquire Trustmark Corporation Creating long-term value for shareholders through compelling combination
−4.3%8-K 7.01 ↗ - SESSES AI CorpResults of operations.−54.2%8-K 2.02 ↗
- SPHSuburban Propane Partners LPResults of operations.
Suburban Propane Partners, L.P. Announces Full Year and Fourth Quarter Results
−6.2%8-K 2.02 ↗ - FRMMFORUM MARKETS IncResults of operations.
Forum Markets Reports Third Quarter 2026 Financial Results Updates 2026 Guidance and Maintains 2027 Revenue Outlook
−34.9%8-K 2.02 ↗ - PNBKPatriot National Bancorp IncRegulation FD disclosure.−0.1%8-K 7.01 ↗
- TOVXTheriva Biologics, IncResults of operations.−25.0%8-K 2.02 ↗
- SLNSilence Therapeutics plcResults of operations.
Silence Therapeutics Highlights Recent Business Achievements and Reports Third Quarter 2026 Financial Results 12 November 2026
+0.2%8-K 2.02 ↗ - IPXGInflection Point Acquisition Corp. VIIMaterial agreement.+0.2%8-K 1.01 ↗
- EUenCore Energy CorpResults of operations.−22.8%8-K 2.02 ↗
- HITHealth In Tech, IncShareholder vote.−31.6%8-K 5.07 ↗
- HUBSHubSpot IncOfficer or director change and Regulation FD disclosure.
HubSpot Announces Leadership Transition: Co-Founder Brian Halligan Returns as Chief Executive Officer to Lead a Refounding of the Company; Karen Burgess Named Next Chief Financial Officer Yamini…
−4.4%8-K 5.02 ↗ - AVLNAvalyn Pharma IncResults of operations.−10.2%8-K 2.02 ↗
- MGTXMeiraGTx Holdings plcResults of operations.−17.6%8-K 2.02 ↗
- PROFProfound Medical CorpOfficer or director change.−18.7%8-K 5.02 ↗
- PRMEPrime Medicine, IncMaterial agreement.−17.4%8-K 1.01 ↗
- WUWestern Union CORegulation FD disclosure and other events.
Western Union Announces Termination of Agreement to Acquire Intermex
−12.0%8-K 1.02 ↗ - LUCDLucid Diagnostics IncResults of operations and Regulation FD disclosure.−2.3%8-K 2.02 ↗
- AKTSAktis Oncology, IncResults of operations.−5.2%8-K 2.02 ↗
- COHNCohen & Co IncResults of operations.
COHEN & COMPANY REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS Board Declares Quarterly Dividend of $0.25
−21.6%8-K 2.02 ↗ - TOIStarling Oncology, IncRegulation FD disclosure.8-K 7.01 ↗
- KYTXKyverna Therapeutics, IncResults of operations.−16.8%8-K 2.02 ↗
- ONCYOncolytics Biotech IncOther events.
Oncolytics Biotech ® Announces Clinical Supply Agreement to Evaluate Pelareorep in Combination with LOQTORZI ® (toripalimab-tpzi) in Squamous Cell Anal Carcinoma Pelareorep and toripalimab combine…
−14.9%8-K 8.01 ↗ - GRCEGrace Therapeutics, IncResults of operations.
Grace Therapeutics Announces Second Quarter 2027 Financial Results, Provides Business Update
−7.8%8-K 2.02 ↗ - MNPRMonopar TherapeuticsResults of operations.
Monopar Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates
−3.8%8-K 2.02 ↗ - BTCSBTCS IncResults of operations and Regulation FD disclosure.
BTCS Reports Record Gross Profit of $3.5 Million and 86% Gross Margin for Third Quarter 2026 Surpasses $6 million full-year gross profit target in nine months as Imperium liquidity pool positions…
−30.6%8-K 2.02 ↗